The Biologics Manufacturing Centre (BMC) is a non-profit organization specializing in end-to-end GMP biomanufacturing. Our state-of-the-art facility supports the secure production of vaccines and biologics for Canada and global partners.
The BMC maximizes production capabilities through a de-risking process, offering comprehensive technology transfer services for engineering, PPQ, and commercial batches of vaccine antigens, including viral vectors, protein subunits, and virus-like particles. With 20+ years of experience, our experts accelerate time-to-market, ensuring precision and industry expertise at every stage.